Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving
surgery more feasible and might be more likely to eradicate micrometastatic …

Purpose The PACS 01 trial compared six cycles of fluorouracil, epirubicin, and cyclophosphamide
(FEC) with a sequential regimen of three cycles of FEC followed by three cycles of …

BACKGROUND The clinicopathologic features of infiltrating lobular carcinoma (ILC), which
represents 5% to 15% of all breast cancers, are still controversial. In particular, the high …

PURPOSE: To determine the incidence and prognostic significance of eradication of cytologically
proven axillary lymph node metastases in breast cancer patients treated with primary …

Genetic and epigenetic alterations have been identified that lead to transcriptional deregulation
in cancers. Genetic mechanisms may affect single genes or regions containing several …

BACKGROUND Microscopic extrascleral involvement and involvement of optic nerve resection
line are accepted risk factors for orbital and/or metastatic disease from retinoblastoma. …

Background/Aims: Mutations in p53, a tumor suppressor gene located on chromosome 17p,
are the most frequent genetic alterations found in human cancers. Increased intracellular …

Purpose The indications of adjuvant chemotherapy for patients with estrogen receptor (ER)–positive
breast cancer are controversial. We analyzed the predictive value of Ki67, HER2, …

BACKGROUND Sarcomas are a rare complication of radiotherapy for breast carcinoma and
patients have a poor prognosis. The incidence, histology, and management of patients with …

Background Breast cancer and obesity represent important public health issues in most
western countries. A number of studies found a negative prognosis effect of obesity or excess of …